Alnylam Pharmaceuticals, Inc.
USD293.52
+2.15 (+0.74%)
CEO
Yvonne L. Greenstreet
IPO Date
2004-06-01
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$295.96
Prev. Close
$291.37
Day Low
$292.01
Day High
$295.96
52W Low
$273.11
52W High
$495.55
Market Cap
$39.19B
Volume
1.34M
| 921 |
| $297.71 |
| 3 Jun 2026 | PYOTT DAVID E I | director | S-Sale | Disposed | 1,175 | $298.91 |
| 3 Jun 2026 | PYOTT DAVID E I | director | S-Sale | Disposed | 1,222 | $299.87 |
| 3 Jun 2026 | PYOTT DAVID E I | director | S-Sale | Disposed | 495 | $300.72 |
| 3 Jun 2026 | PYOTT DAVID E I | director | S-Sale | Disposed | 17 | $302.65 |
| 3 Jun 2026 | PYOTT DAVID E I | director | M-Exempt | Disposed | 3,830 | $70.20 |
| 3 Jun 2026 | Cravatt Benjamin | director | A-Award | Acquired | 4,393 | $295.63 |
| 3 Jun 2026 | Cravatt Benjamin | director: | Disposed | 0 | $0.00 |
| 22 May 2026 | Sigal Charles Elliott | director | A-Award | Acquired | 671 | $0.00 |
| $1,001 - $15,000 |
| 7 Jan 2024 | Josh Gottheimer | Josh Gottheimer | Sale | $1,001 - $15,000 |
| 17 Apr 2023 | Daniel Goldman | Daniel Goldman | Purchase | $15,001 - $50,000 |
| 8 Mar 2023 | Ro Khanna | Ro Khanna | Sale | $1,001 - $15,000 |
| 24 Feb 2023 | Daniel Goldman | Daniel Goldman | Sale | $15,001 - $50,000 |
| 3 Jan 2023 | Ro Khanna | Ro Khanna | Purchase | $1,001 - $15,000 |
| 16 Oct 2022 | Josh Gottheimer | Josh Gottheimer | Purchase | $1,001 - $15,000 |
| 9 Dec 2020 | Josh Gottheimer | Josh Gottheimer | Sale (Full) | $1,001 - $15,000 |